0.39
Athira Pharma Inc Azioni (ATHA) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
-
|
- | - | - | - |
Research and Development |
14.90%
3.661
|
4.302 | 17.92 | 22.15 | 21.24 |
Costs And Expenses |
23.54%
7.291
|
9.536 | 29.62 | 28.03 | 27.69 |
Operating Income/Loss |
23.54%
-7.291
|
-9.536 | -29.62 | -28.03 | -27.69 |
Income/Loss From Continuing Operations Before Tax |
20.26%
-7.291
|
-9.143 | -29.62 | -26.86 | -26.34 |
Income/Loss From Continuing Operations After Tax |
23.81%
-6.966
|
-9.143 | -28.74 | -26.86 | -26.34 |
|
23.81%
-6.966
|
-9.143 | -28.74 | -26.86 | -26.34 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.13%
39.09
|
39.04 | 38.52 | 38.38 | 38.32 |
Diluted Average Shares |
0.13%
39.09
|
39.04 | 38.52 | 38.38 | 38.32 |
Basic Earnings Per Share |
21.74%
-0.18
|
-0.23 | -0.75 | -0.70 | -0.69 |
Diluted Earnings Per Share |
21.74%
-0.18
|
-0.23 | -0.75 | -0.70 | -0.69 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):